ArticleBMJ case reports2022
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis.
Reuben Malloy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it